DrAIStudio

Breast Cancer: Targets and Therapy call for papers

Current call-for-papers opportunities for Breast Cancer: Targets and Therapy. Ranking signals: Indexed (Active), JIF 3.4. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Breast Cancer: Targets and Therapy

Breast Cancer Biomarkers in Diagnostic and Translational Pathology

Deadline 2027-01-31Taylor & FrancisIndexed (Active)

Journal: Breast Cancer: Targets and Therapy

Breast cancer diagnostics has undergone a significant transformation with the expanding integration of immunohistochemistry-based biomarker assessment into routine pathology practice. Beyond traditional morphologic classification, contemporary evaluation increasingly incorporates predictive and prognostic markers. In breast pathology, biomarkers such as hormone receptors and HER2 have long served as foundational too…

Breast Cancer Under Therapeutic Pressure: Adaptive States, Resistance and Emerging Vulnerabilities

Deadline 2027-07-01Taylor & FrancisIndexed (Active)

Journal: Breast Cancer: Targets and Therapy

Breast cancer treatment has advanced substantially through endocrine therapy, chemotherapy, radiotherapy, HER2-targeted agents, CDK4/6 inhibitors, immunotherapy, antibody-drug conjugates, and other emerging strategies. Yet treatment is not simply a process of eliminating cancer cells. It also imposes powerful selective and biological pressures on tumors and their surrounding microenvironment. In response, surviving…

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.